Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma

被引：0
|
作者：
Lan Mu
Ke Ding
Ranran Tu
Wei Yang
机构：
[1] Central South University,Department of Thyroid Surgery, The Second Xiangya Hospital
[2] Central South University,Department of Urology, Xiangya Hospital
[3] Central South University,Department of Neurology, The Second Xiangya Hospital
[4] Central South University,Department of Respiratory Medicine, National Key Clinical Specialty, Xiangya Hospital
来源：
Journal of Translational Medicine | / 19卷
关键词：
Lung adenocarcinoma; Immune infiltration; LncRNA; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma
    Zhao, Yanding
    Varn, Frederick S.
    Cai, Guoshuai
    Xiao, Feifei
    Amos, Christopher I.
    Cheng, Chao
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (01) : 86 - 95
  • [32] Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma
    Bao, Xuanwen
    Shi, Run
    Zhao, Tianyu
    Wang, Yanfang
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2020, 98 (06): : 805 - 818
  • [33] Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma
    Kui Cao
    Mingdong Liu
    Keru Ma
    Xiangyu Jiang
    Jianqun Ma
    Jinhong Zhu
    Cancer Immunology, Immunotherapy, 2022, 71 : 1295 - 1311
  • [34] Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma
    Xuanwen Bao
    Run Shi
    Tianyu Zhao
    Yanfang Wang
    Journal of Molecular Medicine, 2020, 98 : 805 - 818
  • [35] Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma
    Cao, Kui
    Liu, Mingdong
    Ma, Keru
    Jiang, Xiangyu
    Ma, Jianqun
    Zhu, Jinhong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (06) : 1295 - 1311
  • [36] A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma
    Zipei Song
    Xincen Cao
    Xiaokun Wang
    Yuting Li
    Weiran Zhang
    Yuheng Wang
    Liang Chen
    Scientific Reports, 14
  • [37] Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma
    Wang, Jixin
    Yin, Xiangjun
    Zhang, Yin-Qiang
    Ji, Xuming
    FRONTIERS IN GENETICS, 2021, 12
  • [38] A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma
    Song, Zipei
    Cao, Xincen
    Wang, Xiaokun
    Li, Yuting
    Zhang, Weiran
    Wang, Yuheng
    Chen, Liang
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [39] Identification of a novel signature related to the immune landscape and prognosis for human colonic adenocarcinoma based on lncRNA pairs
    Ying Wang
    ZeMin Tian
    ZunJie Zhou
    Lang Chen
    XiaoFeng Zhu
    Kun Yu
    Yuan Qiu
    Journal of Nutritional Oncology, 2024, 9 (04) : 127 - 135
  • [40] Identification and validation of a 4-extracellular matrix gene signature associated with prognosis and immune infiltration in lung adenocarcinoma
    Chai, Yanfei
    Ma, Yuchao
    Feng, Wei
    Xiang, Hong
    Lu, Hongwei
    Jin, Longyu
    HELIYON, 2024, 10 (02)
12345